Shopping Cart
- Remove All
Your shopping cart is currently empty
Setrobuvir (ANA-598) is an orally active non-nucleoside HCV NS5B polymerase inhibitor with inhibitory effects on de novo RNA synthesis and primer extension with IC50s between 4 and 5 nM. setrobuvir shows good binding affinity for SARS-CoV-2 RdRp and induces inhibition of RdRp.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $240 | In Stock | |
| 5 mg | $600 | In Stock | |
| 10 mg | $855 | In Stock | |
| 25 mg | $1,280 | In Stock | |
| 50 mg | $1,750 | In Stock | |
| 100 mg | $2,360 | In Stock | |
| 500 mg | $4,730 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $776 | In Stock |
| Description | Setrobuvir (ANA-598) is an orally active non-nucleoside HCV NS5B polymerase inhibitor with inhibitory effects on de novo RNA synthesis and primer extension with IC50s between 4 and 5 nM. setrobuvir shows good binding affinity for SARS-CoV-2 RdRp and induces inhibition of RdRp. |
| Targets&IC50 | RNA synthesis and primer extension:4~5 nM, HCV NS5B 1a:52 nM (EC50), HCV NS5B 1b:3 nM (EC50) |
| In vivo | Setrobuvir (200, 400, and 800 mg) BID were -2.1, -2.2, and -2.9 log10 IU/mL, respectively (vs ≤0.1 log10 IU/mL with placebo).[3] |
| Synonyms | RO-5466731, RG-7790, RG7790, ANA-598, ANA598 |
| Molecular Weight | 560.62 |
| Formula | C25H25FN4O6S2 |
| Cas No. | 1071517-39-9 |
| Smiles | C(N1[C@@]2([C@@]([C@@]3(C[C@]2(CC3)[H])[H])(C(O)=C(C1=O)C=4NC=5C(S(=O)(=O)N4)=CC(NS(C)(=O)=O)=CC5)[H])[H])C6=CC=C(F)C=C6 |
| Relative Density. | 1.72 g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 252.5 mg/mL (450.39 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.